Cargando…
GSK3β: A Master Player in Depressive Disorder Pathogenesis and Treatment Responsiveness
Glycogen synthase kinase 3β (GSK3β), originally described as a negative regulator of glycogen synthesis, is a molecular hub linking numerous signaling pathways in a cell. Specific GSK3β inhibitors have anti-depressant effects and reduce depressive-like behavior in animal models of depression. Theref...
Autores principales: | Duda, Przemysław, Hajka, Daria, Wójcicka, Olga, Rakus, Dariusz, Gizak, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140610/ https://www.ncbi.nlm.nih.gov/pubmed/32188010 http://dx.doi.org/10.3390/cells9030727 |
Ejemplares similares
-
Expression of Fbp2, a Newly Discovered Constituent of Memory Formation Mechanisms, Is Regulated by Astrocyte–Neuron Crosstalk
por: Hajka, Daria, et al.
Publicado: (2020) -
GSK3 as a Regulator of Cytoskeleton Architecture: Consequences for Health and Disease
por: Hajka, Daria, et al.
Publicado: (2021) -
FBP2—A New Player in Regulation of Motility of Mitochondria and Stability of Microtubules in Cardiomyocytes
por: Pietras, Łukasz, et al.
Publicado: (2022) -
Global quantitative TPA-based proteomics of mouse brain structures reveals significant alterations in expression of proteins involved in neuronal plasticity during aging
por: Duda, Przemysław, et al.
Publicado: (2018) -
The Reverse Warburg Effect Is Associated with Fbp2-Dependent Hif1α Regulation in Cancer Cells Stimulated by Fibroblasts
por: Duda, Przemysław, et al.
Publicado: (2020)